Bluejay Diagnostics Inc (BJDX) — Financial Flexibility Index
Bluejay Diagnostics Inc (BJDX) has a Financial Flexibility Index of -1.11x as of March 2026. Free cash flow of $-1.57 Million (operating CF $-1.59 Million minus capex $18.99K) represents -1% of total liabilities ($1.42 Million). Check BJDX PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Bluejay Diagnostics Inc Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Bluejay Diagnostics Inc across 7 annual periods. See Bluejay Diagnostics Inc working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Bluejay Diagnostics Inc (2019–2025)
Year-by-year free cash flow to debt coverage for Bluejay Diagnostics Inc. For the full company profile including market capitalisation, see BJDX company net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -5.14x | $-5.88 Million | $-6.05 Million | $1.14 Million | ▲ +36.5% |
| 2024 | -8.10x | $-7.51 Million | $-7.82 Million | $927.92K | ▼ -110.0% |
| 2023 | -3.86x | $-7.61 Million | $-8.31 Million | $1.97 Million | ▼ -16.7% |
| 2022 | -3.30x | $-6.54 Million | $-7.74 Million | $1.98 Million | ▲ +51.5% |
| 2021 | -6.82x | $-4.34 Million | $-4.37 Million | $637.16K | ▼ -7947.4% |
| 2020 | -0.08x | $-484.76K | $-508.71K | $5.72 Million | ▲ +80.6% |
| 2019 | -0.44x | $-1.68 Million | $-1.69 Million | $3.85 Million | — |